MY008211A

· Wuhan Createrna Science and Technology Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MY008211A, covering 2024-11-18 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MY008211A in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) [Phase 2]